Journals / Gülhane Tıp Dergisi / 2019 / Cilt: 61 - Sayı: 3

The investigation of alexithymia in patients with Parkinson disease

Pages
93–96
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results:Our results showed TAS scores were significantly higher in PD group (p 0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims:Parkinson Disease (PD) is a neurodegenerative disorder that is thought to be almost particularly featured by motor symptoms and non-motor symptoms such as sleep problems, cognitive impairments, anxiety, and alexithymia.
📊
Key Findings & Data:Methods:This study was conducted on 67 patients with Idiopathic Parkinson Disease (IPD) between ages 57 and 79 who admitted to the Neurology Clinic in Okmeydani Training and Research Hospital and 70 healthy subjects.
💡
Conclusion & Impact:Results:Our results showed TAS scores were significantly higher in PD group (p 0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aims:Parkinson Disease (PD) is a neurodegenerative disorder that is thought to be almost particularly featured by motor symptoms and non-motor symptoms such as sleep problems, cognitive impairments, anxiety, and alexithymia. Methods:This study was conducted on 67 patients with Idiopathic Parkinson Disease (IPD) between ages 57 and 79 who admitted to the Neurology Clinic in Okmeydani Training and Research Hospital and 70 healthy subjects. All participants had given written consent. Alexithymia status were assessed with Toronto Alexithymia Scale (TAS) respectively. Results:Our results showed TAS scores were significantly higher in PD group (p 0.05). Also, our findings showed significant correlation between alexithymia and UPDRS III scores which are higher than 30. One of the novel results in this study that alexithymia was found to be higher in smoked patients with IPD group than non-smoked, but it was not statically significant (p >0.05). Conclusions:The present study suggests that alexithymia may be related with the disease process of IPD and it should be considered in patients with IPD evaluation and management.

🔖

Cite This Article

SONKAYA, A. R., CEYLAN, M. (2019). The investigation of alexithymia in patients with Parkinson disease. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 3, 93–96. https://ajindex.com/articles/159646

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dancis A, Cotter VT. Diagnosis and management of cognitive impairment in parkinson’s disease. The Journal for Nurse Practitioners. 2015;11(3):307-313
  2. Darrow SM, Follette WC. A behavior analytic interpretation of alexithymia. Journal of contextual behavioral science. 2014;3(2):98-108
  3. Sifneos PE. The prevalence of ‘alexithymic’characteristics in psychosomatic patients. J Psychotherapy and psychosomatics. 1973;22(2-6):255-262
  4. Bogdanova Y, Cronin-Golomb A. Alexithymia and apathy in Parkinson’s disease: neurocognitive correlates. J Behavioural neurology. 2013;27(4):535-545
  5. Honkalampi K, Hintikka J, Tanskanen A, Lehtonen J, Viinamäki H. Depression is strongly associated with alexithymia in the general population. Journal of psychosomatic research. 2000;48(1):99-104
  6. Parker JD, Bagby RM, Taylor GJ. Alexithymia and depression: distinct or overlapping constructs? J Comprehensive psychiatry. 1991;32(5):387-394
  7. Poletti M, Frosini D, Pagni C, et al. The association between motor subtypes and alexithymia in de novo Parkinson’s disease. Journal of neurology. 2011;258(6):1042-1045
  8. Assogna F, Palmer K, Pontieri FE, et al. Alexithymia is a non-motor symptom of Parkinson disease. J The American Journal of Geriatric Psychiatry. 2012;20(2):133- 141
  9. Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Prevalence and characteristics of alexithymia in Parkinson’s disease. J Psychosomatics. 2010;51(1):22-28
  10. Costa A, Caltagirone C. Alexithymia in Parkinson’s disease: a point of view on current evidence. J Neurodegenerative disease management. 2016;6(3):215-222
  11. Castelli L, Tonello D, Rizzi L, Zibetti M, Lanotte M, Lopiano L. Alexithymia in patients with Parkinson’s disease treated with DBS of the subthalamic nucleus: a casecontrol study. J Frontiers in psychology. 2014;5:1168
  12. Assogna F, Palmer K, Pontieri FE, et al. Alexithymia is a non-motor symptom of Parkinson disease. The American Journal of Geriatric Psychiatry. 2012;20(2):133-141
  13. Güleç H, Köse S, Güleç M, et al. Yirmi soruluk Toronto aleksimi ölçeğinin Türkçe uyarlamasının geçerlik ve güvenirliğinin incelenmesi. J Klin Psikofarmakol Bul. 2009;19:214-220
  14. Hisli N. Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi.(A reliability and validity study of Beck Depression Inventory in a university student sample). J Psychol. 1989;7:3-13
  15. Salkind M. Beck depression inventory in general practice. J The Journal of the Royal College of Ge